PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5
279.7M
Enterprise Value 3
250.71M
Trailing P/E
N/A
Forward P/E 1
54.80
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2,149.43
Price/Book (mrq)
5.57
Enterprise Value/Revenue 3
1,926.60
Enterprise Value/EBITDA 6
-9.97

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 318.89%
52 Week High 311.5000
52 Week Low 32.5100
50-Day Moving Average 33.1925
200-Day Moving Average 34.9680

Share Statistics

Avg Vol (3 month) 3136.45k
Avg Vol (10 day) 390.72k
Shares Outstanding 597.49M
Float 78.58M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Nov 15, 2019) 43.29M
Short Ratio (Nov 15, 2019) 421.79
Short % of Float (Nov 15, 2019) 4N/A
Short % of Shares Outstanding (Nov 15, 2019) 43.37%
Shares Short (prior month Oct 15, 2019) 43.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 211/1
Last Split Date 3Jan 18, 2019

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-20,512.69%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)130.13k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-36.64k
EBITDA -25.15M
Net Income Avi to Common (ttm)-31.22M
Diluted EPS (ttm)-0.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.8M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)1.38M
Total Debt/Equity (mrq)2.87
Current Ratio (mrq)5.21
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-26.84M
Levered Free Cash Flow (ttm)N/A